Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMortgage Advice Bureau Regulatory News (MAB1)

Share Price Information for Mortgage Advice Bureau (MAB1)

Share Price is delayed by 15 minutes
Get Live Data
532.00    -1.00 (-0.19%)
Bid:
529.00
Ask:
532.00
Spread: 3.00 (0.567%)
Market Cap: £306.51m
MAB1 Live PriceLast checked at - London Stock Exchange

Intraday Mortgage Advice Bureau Share Chart

Block Admission Application

14 Mar 2025 07:00

RNS Number : 6556A
Mortgage Advice Bureau (Hldgs) PLC
14 March 2025
 

14 March 2025

 

 

Mortgage Advice Bureau (Holdings) plc

("MAB" or the "Company")

 

Block Admission Application

 

The Company announces that two block admission applications ("Blocklisting 1" and "Blocklisting 2") have been made to the London Stock Exchange for the admission of an aggregate of 505,000 ordinary shares of 0.1p each in the Company ("Ordinary Shares") to trading on AIM.

 

Both Blocklisting 1 and Blocklisting 2 are expected to become effective at 8:00 am on 20 March 2025.

 

The Ordinary Shares admitted under Blocklisting 1 and Blocklisting 2 will rank pari passu in all respects with the existing Ordinary Shares of the Company. 

 

At the time of this announcement, MAB has 57,956,789 Ordinary Shares in issue. This figure may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in, the share capital of the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

Blocklisting 1

 

The first block admission application is for 187,000 Ordinary Shares ("First Application") and is to be used to facilitate the exercise of options granted under the Mortgage Advice Bureau Executive Option Plan which was approved by the Company on 10 November 2014 (the "2014 Option Plan").

 

This first block admission will supplement the block admission dated 3 April 2019 of 1,068,888 Ordinary Shares for the 2014 Option Plan.

 

Blocklisting 2

 

The second block admission application is for 318,000 Ordinary Shares ("Second Application") to be used to facilitate the exercise of options granted under the Mortgage Advice Bureau Executive Share Option Plan approved by the Company on 26 March 2024 (the "2024 Share Option Plan").

 

Enquiries:

 

Mortgage Advice Bureau (Holdings) plc

Via Camarco

Peter Brodnicki, Chief Executive Officer

Ben Thompson, Deputy Chief Executive Officer

Emilie McCarthy, Chief Financial Officer

Nominated Adviser and Joint Broker

Keefe, Bruyette & Woods, a Stifel Company

Erik Anderson / Nick Harland / Francis North / Harry Billen

 

+44 (0)20 7710 7600

Joint Broker

Peel Hunt LLP

Andrew Buchanan / Oliver Jackson 

 

+44 (0) 20 7418 8900

Financial PR

Camarco

Tom Huddart / Louise Dolan / Letaba Rimell

 

mab@camarco.co.uk

+44 (0) 203 757 4980

Investor Relations

Investor.relations@mab.org.uk

 

About Mortgage Advice Bureau:

 

MAB is one of the UK's leading consumer intermediary brands and specialist networks for mortgage advisers. 

 

Through its partner firms known as Appointed Representatives ("ARs"), MAB has approximately 2,000 advisers providing expert advice to customers on a range of mortgage, specialist lending, protection, and general insurance products. MAB supports its AR firms with proprietary technology and services, including adviser recruitment and lead generation, learning and development, compliance auditing and supervision, and digital marketing and website solutions.

 

For more information, visit www.mortgageadvicebureau.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ALSGPUQGWUPAPWW
Date   Source Headline
22nd May 20247:00 amRNSAGM Statement
17th May 20243:26 pmRNSNotification of Major Holdings
14th May 20244:37 pmRNSDirectors' Shareholdings and PDMR notification
10th May 20247:00 amRNSNotification of Major Holdings
1st May 20247:00 amRNSNotification of Major Holdings
30th Apr 20242:21 pmRNSDirectors' Shareholdings and PDMR notification
25th Apr 20244:40 pmRNSNotice of Results and AGM
23rd Apr 20244:27 pmRNSGrant of Options and Total Voting Rights
23rd Apr 20247:00 amRNSBoard Changes
17th Apr 20244:57 pmRNSPDMR dealing
15th Apr 20246:09 pmRNSDirector/PDMR Shareholding
28th Mar 20244:01 pmRNSDirectors' Shareholdings and PDMR notification
19th Mar 20247:00 amRNSFinal Results for the year ended 31 December 2023
15th Mar 20247:00 amRNSDirectors' Shareholdings and PDMR notification
8th Mar 202411:41 amRNSNotification of Major Holdings
29th Feb 20243:21 pmRNSDirectors' Shareholdings and PDMR notification
23rd Feb 20243:25 pmRNSNotification of Major Holdings
19th Feb 20246:17 pmRNSNotification of Major Holdings
19th Feb 20246:15 pmRNSNotification of Major Holdings
14th Feb 20244:09 pmRNSDirectors' Shareholdings and PDMR notification
9th Feb 20247:00 amRNSNotification of Major Holdings
6th Feb 20243:15 pmRNSNotification of Major Holdings
31st Jan 20243:38 pmRNSDirectors' Shareholdings and PDMR notification
26th Jan 20247:00 amRNSNotification of Major Holdings
25th Jan 20247:00 amRNSTrading Update
15th Jan 20243:15 pmRNSDirectors' Shareholdings and PDMR notification
15th Jan 20247:00 amRNSBoard Change
12th Jan 20241:43 pmRNSBlock listing Interim Review
29th Dec 202311:03 amRNSDirectors' Shareholdings and PDMR notification
15th Dec 202310:26 amRNSDirectors' Shareholdings and PDMR notification
30th Nov 20235:57 pmRNSDirectors' Shareholdings and PDMR notification
21st Nov 202311:49 amRNSNotification of Major Holdings
14th Nov 20234:29 pmRNSDirectors' Shareholdings and PDMR notification
3rd Nov 20233:43 pmRNSDirector/PDMR Shareholding
31st Oct 20234:00 pmRNSDirectors' Shareholdings and PDMR notification
16th Oct 20235:07 pmRNSDirectors' Shareholdings and PDMR notification
12th Oct 202311:10 amRNSNotification of Major Interest in Shares
10th Oct 20231:32 pmRNSNotification of Major Interests in Shares
9th Oct 20235:55 pmRNSNotification of Major Interests in Shares
28th Sep 202312:11 pmRNSNotification of Major Holdings
26th Sep 20237:00 amRNSInterim Results
18th Sep 20232:40 pmRNSDirectors' Shareholdings and PDMR notification
31st Aug 20234:43 pmRNSDirectors' Shareholdings and PDMR notification
14th Aug 20233:24 pmRNSDirector/PDMR Shareholding
10th Aug 20237:00 amRNSStandard form for notification of major holdings
1st Aug 202311:23 amRNSDirector/PDMR Shareholding
26th Jul 20237:00 amRNSTrading Update
21st Jul 20232:59 pmRNSNotification of major holdings
18th Jul 20235:34 pmRNSDirectors' Shareholdings and PDMR notification
17th Jul 202312:43 pmRNSDirectors' Shareholdings and PDMR notification

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.